Chu Dijon Bourgogne
Dijon, 21000, France
NCT Number: NCT03305302
In terms of incidence, cancer of the tongue is one of the leading cancers in France. Moreover, this cancer is associated with physiological complications ranging from swallowing disorders to loss of taste. Following surgery, impaired perception of food taste may lead to cachexia. It is therefore necessary to carry out research in the field of impaired taste, notably with regard to the regeneration of taste buds. However, there is currently no available functional model of taste bud cells.
It is therefore necessary to obtain a cell line of human taste cells. These immortalised human cells will allow us to better orient our investigations for applications in humans: search for and characterisation of "taste modifiers" synthesised using organic chemistry, able to trigger the perception of food in cases of taste loss or taste impairment.
Moreover, given recent studies conducted by the investigating team proposing the existence of a fatty taste and its implication in obesity, the work of the team could be oriented towards the synthesis of lipid-receptor agonists, by analogy with artificial sweeteners instead of sugar. The availability of these chemical molecules would lead to a reduction in lipid intake as these agents contain no (or very few) calories. They will act as an organoleptic decoy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Dijon, 21000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Harvesting and culture of cancerous epithelium from the surgical piece
Time frame: through study completion, an average of 1 year
Centre Hospitalier Universitaire Dijon
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03853655
Buccal Mucosa Cancer, Cancer of Mouth
Guwahati, Assam, India
View Trial DetailsNCT02254278
Carcinoma, Carcinoma, Squamous Cell
Birmingham, Alabama, United States
View Trial DetailsNCT00939627
Carcinoma, Carcinoma, Squamous Cell
Tampa, Florida, United States
View Trial DetailsNCT04540588
Carcinoma, Carcinoma, Basal Cell
Jerusalem, Israel
View Trial Details